Eli Lilly & Co. said its Type-2 Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound drove a 45% increase in ...

Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and ...

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

On an adjusted basis, the U.S. drugmaker expects to earn between $22.50 and $24.00 per share in 2025. Analysts were expecting ...

"I had lost the feeling in my right leg after a botched epidural. I was sleep deprived. I lived off takeaways. My maternity ...

Even really skinny people like to be on Ozempic, especially these people in Hollywood because they don’t get hungry,” says one plastic surgeon.

Body positivity is shifting with the rise of weight-loss drugs and a booming skincare industry. Discover how body neutrality offers a healthier approach.

Have you been trying to lose weight but feel like you’re trying to climb an insurmountable mountain? As you grow older, gaining weight becomes the easiest thing you can do. When left unchecked ...

The "Natural Mounjaro" drink’s appeal lies in its ... Together, these ingredients are said to suppress appetite and promote weight loss. Online, creators are sharing their recipes and claiming ...

citing slower-than-expected growth in sales of its diabetes and weight-loss drugs. “While the U.S. incretin market grew 45% compared to the same quarter last year, our previous guidance had ...

The natural Mounjaro drink has no scientific backing for weight loss effects comparable to FDA-approved tirzepatide While safe to consume, it lacks essential nutrients and shouldn't replace ...